Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
For commercially insured patients: Submit the claim to the patients primary insurance first Submit the remaining out-of-pocket balance to SS&C Health as the secondary payer using the BIN/PCN/GRP/ID found on the savings offer and with an other coverage code 08
Semaglutide for weight loss is given as a subcutaneous injection
The lyophilized format provides significant stability advantages over pre-reconstituted solutions
It is not FDA-approved, is research-use-only, and is not for human consumption
The label for Wegovy includes a warning of the risk of hip fracture: More fractures of the hip and pelvis were reported on WEGOVY than on placebo in female patients: 1% (24/2448) vs
What to expect when you get started You will experience a nurturing environment free from judgment when you walk through the door
US$ 22.41
US$ 25.63
US$ 26.71
US$ 20.32
US$ 29.81
US$ 25.02
US$ 20.10
